Zambia Seals $1.5bn US Health Deal After Data-Sharing Dispute

Zambia's government and the United States signed a five-year health financing agreement in Lusaka on Thursday, drawing a line under months of acrimonious public dispute about what the country was actually trading away. The deal commits Washington to provide roughly $1.5 billion, with Zambia contributing its own funds toward a combined package estimated at about $3.6 billion through 2030. The agreement replaces health support that had flowed through US programmes for years, now restructured as what officials describe as a shift from donor-recipient charity toward shared responsibility.

The path to this signature was fractious. Earlier this year, a leaked draft of the memorandum sparked alarm among civil society groups, HIV advocates, and opposition figures who read it as a capitulation. The Chapter One Foundation, a human rights organization, warned that Zambia risked surrendering citizens' health data wholesale. Treatment Advocacy and Literacy Campaign activists objected to what they saw as one-directional information flow and demanded the full text be made public. Beyond privacy concerns, activists and opposition voices seized on reports linking the health money to preferential access for American companies seeking Zambia's substantial copper and critical mineral reserves. In May, Foreign Minister Mulambo Haimbe called the data terms "unconscionable" and accused Washington of tying the package to minerals. The then-US ambassador, Michael Gonzales, flatly rejected that characterization as false.

The dispute had deeper roots. The US embassy had suspended drug funding after alleging theft of donated medicines—a claim the Zambian government disputed—creating an atmosphere of mutual suspicion that colored negotiations. When the revised agreement was finally ready, Health Minister Roma Chilengi moved to address the firestorm. Clauses requiring Zambia to send biological specimens to the United States had been removed, he said. Individual patient records would not be shared. Data exchange would be confined to information necessary for monitoring and evaluating programmes funded under the deal itself. Officials maintained that the new text protected privacy, intellectual property, and benefit-sharing in ways the draft had not.

Zambia's agreement sits within a broader American strategy that began when President Trump ordered the closure of USAID in January 2025, citing wasteful spending. The agency's dissolution upended health programmes across African countries that had depended on American funding. Kenya, Tanzania, and Uganda have since signed similar bilateral deals requiring greater domestic cost-sharing. Ghana and Zimbabwe rejected comparable arrangements, citing concerns about data-sharing and specimen-collection conditions. The US has framed the shift as making aid more "aligned and effective," arguing that bilateral agreements with shared financial responsibility produce better outcomes than the old donor model.

The human cost of USAID's closure remains contested. Critics argue that the agency's closure slowed detection of the ongoing Ebola outbreak in the Democratic Republic of Congo and constrained the response, pointing to USAID's role in organizing logistics, supplies, and local outreach. Washington disputes this, noting it has contributed $270 million to tackle the epidemic and maintains that current arrangements are more efficient. For Zambia, the new deal is intended to support HIV and AIDS treatment, tuberculosis, malaria, maternal and child health, disease surveillance, and broader health system strengthening, including recruitment of community health workers. The US funding is expected to decline over the five years as Zambia increases its own domestic health spending—a model that assumes growing fiscal capacity and political will to sustain these programmes without American support.